Trials / Completed
CompletedNCT04506411
Turmeric Efficacy for Mobility and Joint Function
Placebo Controlled Randomized Clinical Trial to Evaluate Efficacy of Turmipure Gold® to Improve Joint Function in Subjects With Distinct Kellgren-Lawrence Knee Radiographic Scores
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 177 (actual)
- Sponsor
- Givaudan France Naturals · Industry
- Sex
- All
- Age
- 35 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The objective of the study is to test the capacity of a 12-weeks Turmipure GOLD® supplementation to reduce joint discomfort.
Detailed description
The aim of this clinical study is to determine whether oral administration of Turmipure GOLD® can contribute to the improvement of mobility and joint function in adult population with knee discomfort and with distinct Kellgren-Lawrence (K\&L) knee radiographic scores.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Turmipure GOLD® | TPG: Turmipure GOLD® capsules - 4 capsules once daily- as prescribed |
| DIETARY_SUPPLEMENT | Turmeric rhizome PE 95% curcuminoids | STE: Turmeric rhizome PE 95% curcuminoids - 4 capsules once daily- as prescribed |
| DIETARY_SUPPLEMENT | Placebo | Placebo: Maltodextrin - 4 capsules once daily- as prescribed |
Timeline
- Start date
- 2020-09-24
- Primary completion
- 2023-03-03
- Completion
- 2023-03-03
- First posted
- 2020-08-10
- Last updated
- 2023-05-03
Locations
8 sites across 2 countries: Croatia, Slovenia
Source: ClinicalTrials.gov record NCT04506411. Inclusion in this directory is not an endorsement.